Healthcare sector | Medical Instruments & Supplies industry
| Price | $20.19 |
|---|---|
| Shares Outstanding | 46.06M |
| All-Time Low | $2.52 |
| 52-Week Low | $23.91 |
| Net Cash / Share | $1.09 |
|---|---|
| Net Current Assets / Share | $9.12 |
| Net Tangible Assets / Share | $19.88 |
| Shares Outstanding Ave Change (Annual) | -15.13% |
| Shares Δ YoY | 0.63% |
| Avg CA Burn (Annual %) | -32.85% (as of 2-20-2026) |
| Avg CA Burn (Quarterly %) | -1.51% (as of 2-20-2026) |
| Max Earning Power / Share | $1.56 |
|---|---|
| Adjusted Earning Power |
$-3.19
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.38%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 37.4M (as of 2-20-2026) |
| Avg EBITDA (5Q) | 9.9M (as of 2-20-2026) |
| Avg Net Income (5Y) | 474.4M (as of 2-20-2026) |
| Avg Net Income (5Q) | -13.8M (as of 2-20-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-20-2026 |
| Consecutive Years Paid | No | 2-20-2026 |
| Pays Dividend | No | 2-20-2026 |
| Last Dividend Date | 12-22-21 | |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 2-20-2026 |
| Net Income Positive | No | 2-20-2026 |
| Current Dividend Streak | No | 2-20-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $19.90 | 915.7M ($915,669,000) | 46M (46,017,959) |
| 2025-09-30 | Quarterly | $20.12 | 922.8M ($922,777,000) | 45.9M (45,858,979) |
| 2025-09-30 | Annual | $20.12 | 922.8M ($922,777,000) | 45.9M (45,858,979) |
| 2025-06-30 | Quarterly | $18.82 | 861.9M ($861,884,000) | 45.8M (45,784,841) |
| 2025-03-31 | Quarterly | $19.82 | 907.3M ($907,335,000) | 45.8M (45,776,018) |
| 2024-12-31 | Quarterly | $20.36 | 930.2M ($930,238,000) | 45.7M (45,691,888) |
| 2024-09-30 | Annual | $20.88 | 951.4M ($951,396,000) | 45.6M (45,570,084) |
| 2023-09-30 | Annual | $25.17 | 1.5B ($1,455,860,000) | 57.8M (57,832,378) |
| 2022-09-30 | Annual | $35.61 | 2.7B ($2,671,362,000) | 75M (75,020,256) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2025-09-30 | 593.8M ($593,821,000) |
| 2024-09-30 | 573.4M ($573,448,000) |
| 2023-09-30 | 551.5M ($551,486,000) |
| 2022-09-30 | 555.5M ($555,498,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| 2021-12-02 | $0.1 |
| 2021-09-02 | $0.1 |
| 2021-06-03 | $0.1 |
| 2021-03-04 | $0.1 |
| 2020-12-03 | $0.1 |
| Date | Dividend / Share |
|---|---|
| 2020-09-03 | $0.1 |
| 2020-06-04 | $0.1 |
| 2020-03-05 | $0.1 |
| 2019-12-05 | $0.1 |
| 2019-09-05 | $0.1 |
| 2019-06-06 | $0.1 |
| 2019-02-28 | $0.1 |
| 2018-12-06 | $0.1 |
| 2018-09-06 | $0.1 |
| 2018-05-31 | $0.1 |
| 2018-03-01 | $0.1 |
| 2017-11-30 | $0.1 |
| 2017-09-07 | $0.1 |
| 2017-05-31 | $0.1 |
| 2017-03-01 | $0.1 |
| 2016-11-30 | $0.1 |
| 2016-08-31 | $0.1 |
| 2016-06-01 | $0.1 |
| 2016-03-02 | $0.1 |
| 2015-12-02 | $0.1 |
| 2015-09-02 | $0.1 |
| 2015-06-03 | $0.1 |
| 2015-03-04 | $0.1 |
| 2014-12-03 | $0.1 |
| 2014-09-03 | $0.1 |
| 2014-06-04 | $0.08 |
| 2014-03-05 | $0.08 |
| 2013-12-04 | $0.08 |
| 2013-09-04 | $0.08 |
| 2013-06-05 | $0.08 |
| 2013-03-06 | $0.08 |
| 2012-12-05 | $0.08 |
| 2012-09-05 | $0.08 |
| 2012-06-06 | $0.08 |
| 2012-03-07 | $0.08 |
| 2011-12-07 | $0.08 |
| 2011-09-07 | $0.08 |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-02-09 | 46,061,529 | +43,570 |
| 2026-02-06 | 46,017,959 | +28,381 |
| 2025-12-22 | 45,989,578 | +293 |
| 2025-12-09 | 45,989,285 | +130,306 |
| 2025-11-24 | 45,858,979 | +19,251 |
| 2025-09-22 | 45,839,728 | +28 |
Latest short-interest change: 4,666,214 shares (15.96% of float) | Days to cover: 5.09
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 4,666,214 shares | -406,066 | -8.01% |
| 2026-02-27 | 5,072,280 shares | +887,936 | +21.22% |
| 2026-02-11 | 4,184,344 shares | +126,525 | +3.12% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.